Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 3

2(28.6%)

7Total

N/A(5)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04780867Not ApplicableCompleted

Psychological and Lifestyle Factors on Health Outcomes

Role: collaborator

NCT02498301Not ApplicableCompleted

Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD

Role: collaborator

NCT04921124Phase 3Completed

Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes

Role: collaborator

NCT04332757Not ApplicableUnknown

Postpartum Exercise and Return to Fitness: Optimise Readiness for Military Mums (PERFORM)

Role: collaborator

NCT04196855Phase 3Unknown

Study of Teriparatide in Stress Fracture Healing

Role: collaborator

NCT01618591Not ApplicableTerminated

Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea

Role: collaborator

NCT01505348Not ApplicableCompleted

Effect of Fasting Versus Feeding on the Bone Metabolic Response to Running

Role: collaborator

All 7 trials loaded